EMA Authorised: Orgovyx (relugolix) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency has authorised Orgovyx (relugolix) for the treatment of prostate cancer (prostatic neoplasms) in the European Union, with Accord H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ORGOVYX (RELUGOLIX)

Snippet

Status: Authorised. Therapeutic area: Prostatic Neoplasms. MAH: Accord Healthcare S.L.U.. Decision date: 29/09/2025